Invenio Imaging, founded in 2012 and headquartered in the United States, is paving the way in the battle against cancer through their innovative approach to medical imaging. The company is renowned for its NIO® Laser Imaging System, which synergizes intraoperative histologic imaging with artificial intelligence. This technology has been applied in over 2,500 procedures across leading cancer centers in both the US and Europe.
As a key player in Biotechnology, Health Care, Manufacturing, and Clean Energy sectors, Invenio Imaging has gained recognition with a Medical Design Excellence Award and a CE Mark, signifying its market viability and potential for expansion in Europe. The company was also selected as a Rosenman Innovator.
Most recently, they secured a Non Equity Assistance investment on 06 June 2023 from MedTech Innovator, underscoring investor confidence in their mission to enhance cancer patient care.